Product Information
NYSTATIN 500,000 UNIT/5 ML CUP is a generic product labeled by PAI Holdings LLC, priced at $0.1755 per ML under NDC 00121086800. Its NADAC has been published 91 times since May 22, 2024.
FDA first approved this application on Jan 7, 2016. Its Orange Book therapeutic-equivalence code is AA.
Strength
100000 [USP'U]/mL
Manufacturer
PAI Holdings LLCNDC
00121086800
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
NYSTATINApproval Type
Generic (ANDA)
FDA Application
ANDA203621FDA Approved
1/7/2016
TE Code
AA
On Market Since
7/17/2020
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN 500,000 UNIT/5 ML CUP has been published 91 times since May 22, 2024, and over the history we have for it it has risen 5.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1755 per ML |
|---|---|
| All-time high | $0.1755 (Feb 11, 2026) |
| All-time low | $0.1635 (Jun 19, 2024) |
| 52-week high | $0.1755 |
| 52-week low | $0.1755 |
| Median price | $0.1755 |
| Average price | $0.1722 |
| Largest weekly change | +4.9% (Nov 20, 2024) |
| Weeks tracked | 91 |
| Tracking since | May 22, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
N/A
5Y
N/A
All
+5.6%
Last surveyed Feb 11, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 68% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
PAI Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
NYSTATIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Polyene Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NYSTATIN 500,000 UNIT/5 ML CUP?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN 500,000 UNIT/5 ML CUP, manufactured by PAI Holdings LLC, is $0.1755 per ML (NDC 00121086800), effective Feb 11, 2026.
How has the price of NYSTATIN 500,000 UNIT/5 ML CUP changed over time?
Over the history we have for it, the NADAC for NYSTATIN 500,000 UNIT/5 ML CUP has risen 5.6%. It has been tracked across 91 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for NYSTATIN 500,000 UNIT/5 ML CUP?
Since May 22, 2024, the NADAC for NYSTATIN 500,000 UNIT/5 ML CUP has ranged from a low of $0.1635 (Jun 19, 2024) to a high of $0.1755 (Feb 11, 2026), with a median of $0.1755 per ML.
Are there cheaper alternatives to NYSTATIN 500,000 UNIT/5 ML CUP?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYSTATIN 100,000 UNIT/ML SUSP, is $0.0561 per ML — about 68% below NYSTATIN 500,000 UNIT/5 ML CUP.
Who manufactures NYSTATIN 500,000 UNIT/5 ML CUP?
NYSTATIN 500,000 UNIT/5 ML CUP (NDC 00121086800) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.